Rapidly proliferating cancer cells display distinct nutrient liabilities (Ward & Thompson, 2012), which prompted us to also test for potential metabolic adaptations in response to TBL1 deficiency in pancreatic cancer cells. This evidence concerns the gene TBL1Y and pancreatic neoplasm.